Clinical Trials Logo

Facies clinical trials

View clinical trials related to Facies.

Filter by:

NCT ID: NCT04639427 Recruiting - Covid19 Clinical Trials

Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases

Co-VIS
Start date: February 8, 2021
Phase:
Study type: Observational

The primary objective of the study is to compare the effectiveness of the use of a transparent covering visor with that of the face mask, with or without the use of video sequences, for speech therapy rehabilitation of oral-linguo-facial praxies in the context of the COVID 19 epidemic.

NCT ID: NCT04635319 Recruiting - Facial Asymmetry Clinical Trials

Prevalence of Facial Asymmetry Among Orthodontic Patients

Start date: November 20, 2020
Phase:
Study type: Observational

To estimate the prevalence of facial asymmetry

NCT ID: NCT04631588 Completed - Facial Fine Lines Clinical Trials

Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines

Start date: November 16, 2020
Phase: Phase 1
Study type: Interventional

The main objective of this study is to assess safety and tolerability of Intradermal (ID) BOTOX in participants with facial fine lines.

NCT ID: NCT04622254 Completed - Clinical trials for Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines.

ULTRA II
Start date: November 12, 2020
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the safety and efficacy of NT 201 (active ingredient: Botulinum (neuro)toxin type A, free from complexing proteins) in the combined treatment of wrinkles in the upper face: Horizontal Forehead Lines [HFL], Glabellar Frown Lines [GFL], and Lateral Canthal Lines [LCL]). It is a prospective, randomized, double-blind, placebo-controlled, multicenter study with a placebo-control main period (MP) followed by an open-label extension period (OLEX).

NCT ID: NCT04609020 Completed - Facial Rhytides Clinical Trials

Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment

Start date: February 15, 2023
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to quantify the psychological, social, and emotional impact of comprehensive aesthetic treatment with a portfolio of the Sponsor's products by measuring the change in subject's satisfaction with facial appearance from baseline (before any treatment) to the final study visit

NCT ID: NCT04608500 Completed - Clinical trials for Facial Papulopustular Rosacea

A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Start date: June 1, 2017
Phase: Phase 3
Study type: Interventional

The primary objectives of this study are to determine the efficacy and safety of FMX103 1.5% minocycline foam applied topically once daily for 12 weeks in the treatment of rosacea.

NCT ID: NCT04594213 Completed - Clinical trials for Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines

ULTRA I
Start date: September 23, 2020
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the safety and efficacy of NT 201 (active ingredient: Botulinum (neuro)toxin type A, free from complexing proteins) in the combined treatment of wrinkles in the upper face (Upper Facial Lines [UFL]): Horizontal Forehead Lines [HFL], Glabellar Frown Lines [GFL], and Lateral Canthal Lines [LCL]). It is a prospective, randomized, double-blind, placebo-controlled, multicenter study with a placebo-control main period (MP) followed by an open-label extension (OLEX) period.

NCT ID: NCT04511598 Recruiting - Clinical trials for 3 Dimensional Soft Tissue Facial Analysis

Precision of 3 Dimensional Facial Analysis Using Bellus 3D Face Camera Pro Versus Planmeca ProMax 3D Proface: A Diagnostic Accuracy Study

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Precision of 3 Dimensional Facial Analysis Using "Bellus 3D Face Camera Pro" Versus "Planmeca ProMax 3D Proface" is to be evaluated in comparison to direct anthropometry.

NCT ID: NCT04499040 Not yet recruiting - Clinical trials for Tricho Hepato Enteric Syndrome

Clinical and Biological Characterization of Patients and Collection of Samples

THE-RNA
Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Objectives: Collect clinical and biological data about patients with SD/THE, collect samples of patients; create a secure on line database to collect worldwide data about SD/THE Partners : APHM, HCL, APHP Currently10 patients (8 with TTC37 mutations and 2 with SKIV2l mutations) present a SD/THE and are managed in France in 5 different centers (Marseille, Paris Trousseau, Paris Necker, Paris Robert Debrés, and Lyon). Most of them are followed in hepato-gastro-enterology units for their intractable diarrhea. Three aspects of the disease: intractable diarrhea, immune defect and liver disease are responsible for the main part of the burden of the disease .For each aspect, the investigators will propose a close follow-up with collection of clinical, biochemical, functional and microbial data. Collect of clinical date: during a programmed consultation clinical data about symptom will be collected twice a year. A detailed form will be used for better delineation of the symptoms. These data included growth, symptom (diarrhea, pain …), and clinical signs. Most of these children have recurrent sample for follow up. During them some blood will be take for study the immune side but also the platelet function.

NCT ID: NCT04457492 Terminated - Clinical trials for Facial Nerve Paresis

Functional Electrical Stimulation for Facial Muscles

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Partial or complete facial paralysis is the weakness of muscles of facial expression. Facial paralysis causes physical, social and emotional problems. Functional electrical stimulation (FES) for facial paralysis is a technique in which muscles are electrically stimulated, causing them to contract This study is designed to help patients with facial nerve weakness.